article thumbnail

Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform

Drug Topics

GLP-1 Usage Does Not Increased Risk of Psychiatric Events, Study Finds Ashley Gallagher May 19th 2025 Article Glucagon-like peptide-1 receptor agonists have been associated with improvements in quality of life (QOL), restrained eating, and emotional eating behavior.

article thumbnail

Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable

Drug Topics

link] Recent Videos Related Content Eli Lilly Adds Highest Doses of Zepbound to Online Pharmacy Platform Ashley Gallagher June 16th 2025 Article Providers can prescribe the 12.5 mg and 15 mg vials of tirzepatide starting July 7, with shipments beginning in early August.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT

The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many patients are left with no good options.  Businesses are changing prescriptions, mixing in additives, or encouraging stockpiling of existing compounded products. Some have disappeared altogether.

article thumbnail

What is compounded semaglutide made of?

The Checkup by Singlecare

Ozempic and Wegovy are also used to reduce the risk of major cardiovascular events. Due to the rising demand for weight loss drugs and the resulting drug shortages , some specialized compounding pharmacies make compounded semaglutide injections. There are a few times when compounding is necessary.

article thumbnail

FDA Approves Nitisinone for Treatment of Alkaptonuria

Drug Topics

3 As for adverse events (AE), 6 patients in the treatment group experienced a serious AE, which included anemia, atrial fibrillation, keratitis, bile duct stone, liver enzyme elevation, sarcoidosis, accidental overdose, and muscle injury.

FDA 343
article thumbnail

GLP-1s Associated With Increased Risk of Neovascular Age-Related Macular Degeneration

Drug Topics

These findings suggest clinicians should be aware of the potential ocular complications associated with GLP-1 RA use and are encouraged to report any suspected adverse events to postmarketing pharmacovigilance systems to facilitate safety tracking and raise public awareness,” the authors concluded. JAMA Ophthalmol. 2022;140(12):1202–1208.

article thumbnail

Pharmacist Involvement Helps Reduce Time to A1c Target

Drug Topics

Recent Videos Related Content Diabetes Risk Reduction Practices Low for Women With Gestational Diabetes Ashley Gallagher June 13th 2025 Article For women in rural populations, access to education and care is limited, causing disparities in diabetes care.